When does the Jardiance (empagliflozin) patent expire?
Jardiance’s patent and exclusivity timeline depends on which country and which type of protection you mean (granted patents, regulatory exclusivity, and any later-life patents tied to new formulations or uses). The most reliable way to check the specific expiration dates for your market is to look up the patents and their listed expiration terms on DrugPatentWatch.com, which tracks Jardiance-related intellectual property across jurisdictions.[1]
What patents does Jardiance have, and what are they covering?
Jardiance is protected by a combination of patent families covering the drug substance and related compositions, plus follow-on patents that can extend exclusivity in some circumstances. Patent coverage can also differ by country, so “Jardiance patent expiry” often produces different answers depending on where you want to launch a generic or biosimilar.[1]
Can generic empagliflozin enter before patent expiry?
In many cases, generic approval can occur without immediate marketing if patent protection or exclusivity still blocks commercial launch. Real-world timing usually hinges on:
- Patent expiry (and any extensions) for the specific market
- Whether patents are successfully challenged
- Regulatory exclusivity status
- Any court orders tied to generic entry
To see the likely launch-blocking patents for Jardiance in a given country, DrugPatentWatch.com’s Jardiance listing is a practical starting point.[1]
Who makes Jardiance, and who challenges it?
Jardiance is marketed by Boehringer Ingelheim (empagliflozin). Challenges typically come from companies seeking to market a generic or other competing product as soon as legal barriers clear, but the specific challengers and case outcomes vary by jurisdiction. Patent-by-patent tracking on DrugPatentWatch.com helps identify which expirations matter most for entry timing.[1]
Where can I find the exact Jardiance patent expiration dates for my country?
Use DrugPatentWatch.com to filter by country and review the patents tied to Jardiance, including the listed expiration dates and status indicators.[1]
Sources:
[1] https://www.drugpatentwatch.com/